发明名称 OSTEOCALCIN PROMOTER DIRECTED ADENOVIRUS REPLICATON FOR THERAPY
摘要 The present invention relates to replication-competent adenovirus vectors which are specific for cells which allow an osteocalcin transcriptional regulatory sequence to function, such as prostate cancer cells, prostate stromal cells, vascular pericytes, proliferating cancer-associated osteoblasts, and prostate cancer and associated bone stromal cells which fai l to express PSA or androgen receptor (AR), and methods of use of such viruses are provided. These viruses comprise an adenoviral gene under control of an osteocalcin transcriptional regulatory sequence. The gene can be, for exampl e, a gene required for adenoviral replication. The viruses can also comprise at least one additional adenoviral gene under control of at least one additiona l tissue-specific transcriptional regulatory sequence. Thus, virus replication can be restricted to target cells exhibiting osteocalcin gene expression. Su ch replication-competent adenovirus vectors are useful in the treatment of prostate cancer, brain cancer, ovarian cancer, thyroid cancer, tumors, osteosarcoma, occular melanoma, lung cancer, or breast cancer.
申请公布号 CA2403795(A1) 申请公布日期 2001.09.27
申请号 CA20012403795 申请日期 2001.03.21
申请人 THE UNIVERSITY OF VIRGINIA PATENT FOUNDATION 发明人 CHUNG, LELAND W. K.;KO, SONG-CHU;GARDNER, THOMAS A.;KAO, CHINGHAI
分类号 C12N15/09;A61K35/76;A61K48/00;A61P9/10;A61P13/08;A61P35/00;A61P35/04;A61P43/00;C12N1/15;C12N1/19;C12N1/21;C12N5/02;C12N5/10;C12N7/00;C12N15/861;C12Q1/02;C12Q1/68;(IPC1-7):C12N5/00;A01N63/00;C12N15/00;C12N15/63;C12N15/70;C12N15/74;C12N15/85;C12N15/86;C12N15/87 主分类号 C12N15/09
代理机构 代理人
主权项
地址